Knowledgeable certified specialty pharmacist with many years of experience in specialty pharmacy management as well as pharmaceutical specialty pharmacy account managing and optimization strategy by unique planning and problem-solving abilities. Focused on maximizing resource utilization while building a patient centered pharmacy approach to aid the needs of patients, caregivers and providers. Organized and systematic with natural relationship-building and leadership talents.
Monitored multiple Specialty Pharmacy performances including working with Market Access exploring ways to maximize the payer access, patient experience, developing and maintaining key account relationships.
Provided education aligned with Market Access team members to east regional payer accounts and many regional Specialty pharmacies as well as IDN Specialty Pharmacies on specific product support offerings around Copaxone, Cinqair, Granix and Austedo including but not limited to HUB programs and financial assistance programs (PAP). Monitored Specialty Pharmacy programs and trends collaborating internally to maximize strategies that drive better market access, patient compliance and adherence.
Managed Specialty Pharmacy Accounts: Briova, Accredo, Chartwell, Pharmacy Advantage, Magellan, Perform RX, Walgreens Specialty, Prime Specialty, Cigna Specialty, Senderra, Welldyne, Cardinal Specialty, Vanderbilt Specialty Pharmacy, UAB Specialty Pharmacy, Cleveland
Clinic Specialty Pharmacy, BioPlus, Vital Care, Vital RX, Allcare Plus, Reliance Rx, Biologics, Apex Specialty Pharmacy, Acentrus, Excellera, Shared Solution Pharmacy
Payer Accounts: Express Scripts, UnitedHealthcare, Prime Therapeutics, Cigna, Aetna, UPMC, Harvard Pilgrim, Magellan, Perform, MVP, Boston Medical Center
Provided strategic channel planning for Copaxone, Austedo and Fermanezamab as well as specialty generics.
· Collaborated internally to develop innovative pharmacy distribution models for Austedo when approved for Huntington’s Disease as well as developing the initiative to opening dispensing network with the Tardive Dyskinesia FDA approval.
· Engaged with Specialty Pharmacy partners regarding limited distribution networks providing education for limited access and how to work with network pharmacy
· Analyze network access for new product launches. Worked with legal to establish contracts and assisted in implementation / integration.
· Established cross-functional group to monitor product field success and market access for Copaxone with the generic version coming to market providing proper communication to keep proper awareness for developing trends.
· Engaged with legal on Pharmacy Benefit Management contracts for Shared Solution Pharmacy
· Collaborated with Cinqair Brand teams to open network access via distribution thru ASD depot model
Pharmacy Channel Specialist